Posted in | News

Cree Announces Benefits of LED Lighting

Cree, Inc. (NASDAQ: CREE), a market leader in LED solid-state lighting components, today announced the results of a new survey on the adoption, deployment and overall benefits of LED lighting. Conducted for Cree this week at Light+Building 2006 in Frankfurt, Germany, the industry’s most prominent biennial trade show, the survey revealed extraordinary optimism among lighting industry executives, architects, designers, engineers and other decision-makers regarding the growth of the LED lighting market.

Out of 123 trade show participants polled, 50 percent of respondents stated they have seen a 20 percent to 60 percent growth rate for LED lighting applications in their businesses over just the past six months. Looking forward, 50 percent of those polled stated their belief that LED lighting will represent more than half of their sales or installations by 2009. Furthermore, 61 percent of respondents believe LED lighting will replace fluorescent lighting in office and commercial spaces within five years. The results indicate an increasingly pervasive acceptance and awareness of the benefits of LED lighting, which include energy savings, long life, high quality of light and the ability to use LED lights in innovative and inspiring new light fixtures and applications.

“The results of this survey reflect what we have been hearing from our customers, both at Light+Building 2006 and in general,” said Mark McClear, Cree director of marketing for lighting LEDs. “We believe results showing the expected transition to LED lighting over the next few years validate the benefits offered by LEDs and confirm Cree’s belief that the lighting market is on the verge of a major shift. The brightness and efficiency offered by Cree’s XLamp® LEDs are helping to position Cree to lead this transition.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.